Myriad Genetics, Inc. (MYGN)
3.97
-0.25
(-5.92%)
USD |
NASDAQ |
May 29, 16:00
4.00
+0.03
(+0.76%)
After-Hours: 05:09
Myriad Genetics EPS Diluted (Quarterly) : -0.3639 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Natera, Inc. | -0.6013 |
| BioRestorative Therapies, Inc. | -0.1215 |
| CareDx, Inc. | 0.0529 |
| Exagen, Inc. | -0.1663 |
| Sera Prognostics, Inc. | -0.1671 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.10M |
| Revenue (Quarterly) | 200.40M |
| Total Expenses (Quarterly) | 234.50M |
| Enterprise Value | 462.06M |
| Gross Profit Margin (Quarterly) | 64.72% |
| Profit Margin (Quarterly) | -17.02% |
| Earnings Yield | -108.7% |
| Normalized Earnings Yield | -46.82 |